Johnson & Johnson vs. Summit Therapeutics Inc. Common Stock
Johnson & Johnson and Summit Therapeutics Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | SMMT | |
|---|---|---|
| Market Cap | $652.48 billion | $12.58 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | SMMT | |
|---|---|---|
| Dividend Yield | 1.98% | — |
JNJ and SMMT split the dividend factors evenly.
Risk & Sentiment
| JNJ | SMMT | |
|---|---|---|
| Short Interest | 0.67% | 0.00% |
SMMT leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SMMT overview, SMMT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.